EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Probiotic Combination of Lactiplantibacillus plantarum DM083 and Lacticaseibacillus rhamnosus DM163 Improves Glycemic Control and Insulin Resistance in High-Fat-Diet-Induced Obese Mice

Jeong-Hoo Lee iD, Je-Hyun Eom iD, Seung-Jo Yang iD, Jiyoung Hwang, Jam-Eon Park iD, Seung-Hwan Park iD, Young-Youn Kim iD, Hye-Sung Kim

Nutrients · 28.06.2026 · 18 (13) · 2107

DOI: 10.3390/nu18132107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 28.06.2026. Verfasst von Jeong-Hoo Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: R&D Center, DOCSMEDI Co., Ltd., Goyang 10387, Republic of Korea. Hauptthemen laut MEDLINE: Insulin Resistance, Probiotics, Obesity, Glycemic Control. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: DOCSMEDI Co., Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Type 2 diabetes mellitus (T2DM) is closely associated with obesity, insulin resistance, and gut microbiota dysbiosis. This study investigated the effects of a probiotic combination of Lactiplantibacillus plantarum DM083 and Lacticaseibacillus rhamnosus DM163 on glycemic control, insulin resistance, gut microbiota composition, and metabolic parameters in high-fat-diet (HFD)-induced obese mice.

Methods

Male C57BL/6 mice were fed a 60% HFD for 8 weeks and subsequently administered DM083/163 (1 × 109, 5 × 109, or 1 × 1010 CFU/day) or metformin (250 mg/kg/day) for 12 weeks. Glucose metabolism, insulin resistance, hepatic gene expression, gut microbiota composition, and fecal short-chain fatty acids (SCFAs) were evaluated.

Results

DM083/163 supplementation at 1 × 1010 CFU/day significantly reduced fasting blood glucose, HbA1c, oral glucose tolerance test area under the curve, and HOMA-IR compared with the HFD control group (p < 0.05). Hepatic expression of the gluconeogenic genes Pck1 and G6pc was significantly downregulated, accompanied by reduced hepatic and serum TNF-α levels. Gut microbiota analysis revealed significant overall differences in beta diversity across groups (PERMANOVA, R2 = 0.262, p = 0.001), driven primarily by diet, with a trend toward a reduced Bacillota/Bacteroidota ratio in the high-dose group.

Conclusions

DM083/163 supplementation improved glycemic control and insulin resistance in HFD-induced obese mice. These effects were associated with suppression of hepatic gluconeogenesis, attenuation of inflammation, and increased SCFA production, findings that are consistent with, but do not establish, modulation of the gut–liver axis. These findings support the potential use of DM083/163 as a probiotic intervention for obesity-associated T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceProbioticsObesityGlycemic ControlLacticaseibacillus rhamnosusLactobacillaceaeAnimalsDiet, High-FatMaleMice, Inbred C57BLMiceBlood GlucoseLiverDiabetes Mellitus, Type 2Gastrointestinal MicrobiomeFatty Acids, VolatileMice, ObeseGluconeogenesis

Stichwörter der Autor:innen

Lacticaseibacillus rhamnosusLactiplantibacillus plantarumglucose tolerancegut microbiotahepatic gluconeogenesishigh-fat dietinsulin resistanceprobioticsshort-chain fatty acidstype 2 diabetes

Substanzen

Blood GlucoseFatty Acids, Volatile

Autor:innen und Institutionen

  • R&D Center, DOCSMEDI Co., Ltd., Goyang 10387, Republic of Korea.
  • Apple Tree Institute of Biomedical Science, Apple Tree Medical Foundation, Goyang 10387, Republic of Korea.
  • Biological Resource Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Jeongeup 56212, Republic of Korea.
  • Apple Tree Dental Hospital, Apple Tree Medical Foundation, Goyang 10387, Republic of Korea.

ORCID-Profile: Jeong-Hoo Lee, Je-Hyun Eom, Seung-Jo Yang, Jam-Eon Park, Seung-Hwan Park, Young-Youn Kim

Förderung

  • DOCSMEDI Co., Ltd

Zitieren

APA

Lee, J. H., Eom, J. H., Yang, S. J., Hwang, J., Park, J. E., Park, S. H., Kim, Y. Y., & Kim, H. S. (2026). A Probiotic Combination of Lactiplantibacillus plantarum DM083 and Lacticaseibacillus rhamnosus DM163 Improves Glycemic Control and Insulin Resistance in High-Fat-Diet-Induced Obese Mice. Nutrients, 18(13), 2107. https://doi.org/10.3390/nu18132107

Vancouver

Lee JH, Eom JH, Yang SJ, Hwang J, Park JE, Park SH, et al. A Probiotic Combination of Lactiplantibacillus plantarum DM083 and Lacticaseibacillus rhamnosus DM163 Improves Glycemic Control and Insulin Resistance in High-Fat-Diet-Induced Obese Mice. Nutrients. 2026;18(13):2107. doi:10.3390/nu18132107

BibTeX
@article{Lee2026,
  author = {Lee, Jeong-Hoo and Eom, Je-Hyun and Yang, Seung-Jo and Hwang, Jiyoung and Park, Jam-Eon and Park, Seung-Hwan and Kim, Young-Youn and Kim, Hye-Sung},
  title = {A Probiotic Combination of Lactiplantibacillus plantarum DM083 and Lacticaseibacillus rhamnosus DM163 Improves Glycemic Control and Insulin Resistance in High-Fat-Diet-Induced Obese Mice},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2107},
  doi = {10.3390/nu18132107}
}
Kostenlos starten →